Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Dexrazoxane × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 3 Sarcoma 2 Rhabdomyosarcoma 2 Myelodysplastic Syndromes 2 Leukemia, Biphenotypic, Acute 2 Ganglioneuroblastoma 2 Sarcoma, Myeloid 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Malignant mesenchymal tumor 1 Lymphoma, Large B-Cell, Diffuse 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia 1 Heart Failure 1 Drug-Related Side Effects and Adverse Reactions 1 Dendritic Cell Sarcoma, Interdigitating 1 Degradation of Top2b and Top2a in Human by Dexrazoxane 1 Cardiotoxicity 1 Burkitt Lymphoma 1 Blast Crisis 1

Interventions

Magnetic Resonance Spectroscopy 9 Specimen Handling 8 X-Rays 6 Phantoms, Imaging 6 Biopsy 6 Nuclear Medicine Department, Hospital 4 Nivolumab 4 Cyclophosphamide 4 Carboplatin 4 selpercatinib 3 larotrectinib 3 Temozolomide 3 Etoposide 3 Cisplatin 3 Automobiles 3 tazemetostat 2 pembrolizumab 2 fludarabine 2 erdafitinib 2 entrectinib 2 ensartinib 2 cabozantinib 2 Vincristine 2 Topotecan 2 Surveys and Questionnaires 2 Radiotherapy 2 Radiosurgery 2 Positron-Emission Tomography 2 ONC206 2 Methotrexate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡